SC 13G

Company

Arbutus Biopharma Corp

Filed

December 9, 2019

Accession Number

0001104659-19-070902

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →